Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Viral Infectivity Factor: A Novel Therapeutic Strategy to Block HIV-1 Replication

Author(s): Guliang Yang and Xujie Xiong

Volume 13, Issue 7, 2013

Page: [1047 - 1055] Pages: 9

DOI: 10.2174/1389557511313070008

Price: $65

Abstract

The HIV-1 viral infectivity factor (Vif), one of the six accessory proteins, is essential for viral replication and pathogenesis. Its main function is to form Vif-Cullin5-ElonginBC complex and then is able to ubiquitinate and degrade the human anti-viral factor APOBEC3G, which markedly enhances the virus infectivity. Delete Vif leads to the loss of the infectivity of HIV-1; therefore, Vif is a potentially new attractive target for therapeutic intervention in AIDS. This review describes the structure, function and especially inhibitors of HIV-1 Vif.

Keywords: HIV-1, accessory proteins, Vif, structure, function, inhibitors.


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy